103 related articles for article (PubMed ID: 3390371)
1. Verapamil sensitizes normal and neoplastic rodent intestinal tissues to the stathmokinetic effect of vincristine in vivo.
Ince P; Appleton DR; Finney KJ; Moorghen M; Sunter JP; Watson AJ
Br J Cancer; 1988 Apr; 57(4):348-52. PubMed ID: 3390371
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of vincristine resistance in primary intestinal neoplasms in the rat by the 'post-metaphase index'.
Ince P; Finney KJ; Appleton DR; Sunter JP; Watson AJ
Br J Cancer; 1985 Oct; 52(4):599-605. PubMed ID: 4063135
[TBL] [Abstract][Full Text] [Related]
3. Modulation by verapamil of vincristine pharmacokinetics and sensitivity to metaphase arrest of the normal rat colon in organ culture.
Ince P; Elliott K; Appleton DR; Moorghen M; Finney KJ; Sunter JP; Harris AL; Watson AJ
Biochem Pharmacol; 1991 Apr; 41(8):1217-25. PubMed ID: 2009097
[TBL] [Abstract][Full Text] [Related]
4. Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine.
Ince P; Appleton DR; Finney KJ; Sunter JP; Watson AJ
Br J Cancer; 1986 Jan; 53(1):137-9. PubMed ID: 3947510
[No Abstract] [Full Text] [Related]
5. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles.
Song XR; Cai Z; Zheng Y; He G; Cui FY; Gong DQ; Hou SX; Xiong SJ; Lei XJ; Wei YQ
Eur J Pharm Sci; 2009 Jun; 37(3-4):300-5. PubMed ID: 19491019
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin, vincristine, and actinomycin-D, but not teniposide, require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug-resistant cells.
Toffoli G; Tumiotto L; Gigante M; Perin T; Biscontin G; Boiocchi M
Cancer Detect Prev; 1993; 17(3):425-32. PubMed ID: 8402730
[TBL] [Abstract][Full Text] [Related]
7. Importance of clinical exposure on verapamil enhancement of adriamycin-vincristine cytotoxicity in human neuroblastoma.
Helson L; Member B; Helson C
Cancer Drug Deliv; 1984; 1(4):303-5. PubMed ID: 6544127
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.
Miller TP; Grogan TM; Dalton WS; Spier CM; Scheper RJ; Salmon SE
J Clin Oncol; 1991 Jan; 9(1):17-24. PubMed ID: 1670642
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
Dalton WS; Grogan TM; Meltzer PS; Scheper RJ; Durie BG; Taylor CW; Miller TP; Salmon SE
J Clin Oncol; 1989 Apr; 7(4):415-24. PubMed ID: 2564428
[TBL] [Abstract][Full Text] [Related]
10. Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells.
Malik IA; Costea NV
Hematol Oncol; 1992; 10(3-4):225-31. PubMed ID: 1398518
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).
Twentyman PR; Reeve JG; Koch G; Wright KA
Br J Cancer; 1990 Jul; 62(1):89-95. PubMed ID: 1975203
[TBL] [Abstract][Full Text] [Related]
12. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
14. A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group.
Milroy R
Br J Cancer; 1993 Oct; 68(4):813-8. PubMed ID: 8398713
[TBL] [Abstract][Full Text] [Related]
15. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
[TBL] [Abstract][Full Text] [Related]
16. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
Wang J; Xia Y; Wang H; Hou Z
Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
[TBL] [Abstract][Full Text] [Related]
17. [ Action of low doses of vincristine, lidocaine and verapamil on DNA replication in vitro].
Vietti Ramus G; Cesano L; Barbalonga A; Pallisco O
Minerva Med; 1986 May; 77(21):917-22. PubMed ID: 3487751
[TBL] [Abstract][Full Text] [Related]
18. Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line.
Harmon BV; Takano YS; Winterford CM; Potten CS
Cell Prolif; 1992 Nov; 25(6):523-36. PubMed ID: 1457603
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
Ishida Y; Shimada Y; Shimoyama M
Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
